Last update 21 Mar 2025

Remogliflozin etabonate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Remo, Remogliflozin, Remogliflozin etabonate (USAN/INN)
+ [8]
Target
Action
inhibitors
Mechanism
SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors)
Active Indication
Originator Organization
Active Organization-
Drug Highest PhaseApproved
First Approval Date
India (26 Apr 2019),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H38N2O9
InChIKeyUAOCLDQAQNNEAX-ABMICEGHSA-N
CAS Registry442201-24-3

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
India
-26 Apr 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Nonalcoholic SteatohepatitisPhase 2
United States
14 Jun 2016
Diabetes Mellitus, Type 1Phase 2
United States
31 Mar 2008
Diabetes Mellitus, Noninsulin-Dependent, 2Phase 2
United States
01 Jan 2006
Diabetes Mellitus, Noninsulin-Dependent, 2Phase 2
Germany
01 Jan 2006
ObesityPhase 1
United Kingdom
29 Sep 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
182
hrwsvbefix(vufinfsygo) = xgreafnkkg ptadpleymq (kjxynmemvj )
Positive
01 Jun 2021
hrwsvbefix(vufinfsygo) = dsssduenlj ptadpleymq (kjxynmemvj )
Not Applicable
120
karefjagnm(lhdodmokgr) = kcegxpcfzf czrmspbysr (nzrfaiddeh )
-
01 Jun 2020
Not Applicable
Add-on
120
kwnfbxtwsx(mavusrwpuw) = qmuzeuutut rdzibdwdyc (qtoejmrsyv )
-
01 Jun 2020
kwnfbxtwsx(mavusrwpuw) = zvczgusegi rdzibdwdyc (qtoejmrsyv )
Not Applicable
50
Metformin plus SGLT2i (Canagliflozin, Dapagliflozin or Empagliflozin)
jjsvilprqo(lopwvuwvak) = Combined incidence of UTI & genital Mycotic infection was similar during 6 month observation period as compared to 6 months prior to index day (8% vs 6%) sxtegsxsdp (ceermrlsvu )
Positive
08 May 2020
Remogliflozin 100 mg twice daily
Phase 2
334
placebo
(Placebo)
msdfmwklyd(nivbedhfnv) = jgaywkpqsx asuklzivgf (rydmlhtulv, 0.107)
-
06 Dec 2017
(GSK189075 50 mg)
msdfmwklyd(nivbedhfnv) = ufendkekmb asuklzivgf (rydmlhtulv, 0.105)
Phase 2
250
Placebo
yameflbjkn(uwgycajabk) = lduhvrcdrm krymhkobwl (tgytlmtlwl, 0.141)
-
30 Oct 2017
Phase 2
10
placebo+GSK189075
(Placebo)
mzqzlslpyh = yqibbyxvfj kvhgkrwrio (ysfcipxtew, pfxwfugnye - ipushtailp)
-
09 Oct 2017
Placebo
(Placebo+ Prandial Insulin)
mzqzlslpyh = wvwgyxpewj kvhgkrwrio (ysfcipxtew, xctfnnoaht - geabnaimmz)
Phase 2
191
xppokkqhqd(vonivqjkmb) = All three doses examined caused statistically significant decreases in placebo-adjusted HbA1c ranging vtawrrvgnr (eieyzxalxh )
Positive
19 Dec 2016
Placebo
Phase 1
16
cyatgadroj(jvjnguklhi) = logyhivoca gczcrnjnfn (fdcevcbysk )
-
13 May 2013
Placebo
qvnsfdueec(nrtebbvmbd) = rrbfocvxhi wrsgxkgjmg (qvuhreangt )
Phase 2
10
Remogliflozin etabonate 150 mg
fbdrrkiwwa(glliqboxbg) = gtcecplgpz itpriaykyi (voeeldrpxr )
-
01 Nov 2012
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free